COMMUNIQUÉS West-GlobeNewswire

Aptose Announces Deferral of Interest Payment
30/06/2025
SAN DIEGO and TORONTO, June 30, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple [...]
Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30/06/2025
BOSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation antibody-drug conjugate (‘ADC’) therapeutics for difficult-to-treat cancers, reported [...]
PetVivo Reports Fiscal 2025 Results
30/06/2025
MINNEAPOLIS, MN, US, June 30, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. and its wholly-owned subsidiary PetVivo Animal Health, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leading biomedical company delivering innovative [...]
INmune Bio, Inc. Announces Closing of Approximately $19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
30/06/2025
Boca Raton, Florida, June 30, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company, today announced that it has closed its registered direct [...]
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
30/06/2025
WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Crinetics to Showcase the Next Generation of Endocrinology Innovation at ENDO 2025 with Eight Presentations From its Deep Pipeline
30/06/2025
Long-term efficacy and safety data on PALSONIFY TM (paltusotine) in acromegaly to be presented, including evidence of both biochemical and symptom control with a well-tolerated safety profile in patients switching [...]
Gain Therapeutics Announces Completion of Target Enrollment in Phase 1b Clinical Study Evaluating GT-02287 in People With Parkinson’s Disease With or Without a GBA1 Mutation
30/06/2025
As of June 30 th , 16 participants have enrolled in the Phase 1b, ahead of the original goal of at least 15 total participants by 3Q 2025 Analysis of 90-day biomarker activity from cerebrospinal fluid (CSF) in all [...]
I-Mab Announces Publication of Givastomig Monotherapy Data in Clinical Cancer Research
30/06/2025
Monotherapy efficacy and safety profile provided backbone for clinical development strategy in 1L combination with nivolumab plus chemotherapy ROCKVILLE, MD, June 30, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the [...]
Dyne Therapeutics Secures Up to $275 Million in Debt Financing from Hercules Capital
30/06/2025
- $100 million funded upfront; additional $175 million tied to milestones provides strategic flexibility through key inflection points - WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq [...]
Strongest Appetite Suppressant Over the Counter Now Available in USA - PhenQ Medically Accredited Craving Control Supplement OTC
30/06/2025
Clinicians’ Choice Appetite Suppressant, PhenQ: Medically Accredited by 800 Professionals and Now Launched in the USA Without Prescription New York City, NY, June 30, 2025 (GLOBE NEWSWIRE) -- For Americans seeking the [...]
Jupiter Neurosciences Showcases Nugevia™ PWR: Mitochondrial Optimization Supplement Designed to Boost Energy, Endurance, and Recovery
30/06/2025
PWR delivers science-driven cellular energy and recovery support as part of Jupiter’s expanding longevity supplement portfolio Jupiter, Florida, June 30, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: [...]
theranos Calls on President Trump to Pardon Suresh “Sunny” Balwani
30/06/2025
PALM BEACH, Fla., June 30, 2025 (GLOBE NEWSWIRE) -- After calling on President Trump last Friday to pardon Elizabeth Holmes, Ryan ElHosseiny, current CEO and inventor behind the revived theranos, now also urges the [...]
Human Appeal Announces First Summer UK Comedy Tour
30/06/2025
MANCHESTER, United Kingdom, June 30, 2025 (GLOBE NEWSWIRE) -- Following the roaring success of its annual winter Comedy Tour over the last decade, one of the UK’s leading humanitarian aid charities, Human Appeal, today [...]
Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters
30/06/2025
Contribution highlights leadership’s understanding of the importance AI will play in drug discovery WARREN, N.J., June 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) [...]
The Real Jerry Maguire Meets Prof. Mike Chan of European Wellness Biomedical Group to Discuss Sports Injuries and Concussion Recovery
30/06/2025
The man who inspired the multiple award-winning movie “Jerry Maguire” meets the pioneering stem cell scientist who is transforming regenerative medicine. Together, they may just hold the key to healing the silent [...]
More Tests, No Insurance Needed: HNL Lab Medicine Grows Self-Pay Offerings
30/06/2025
ALLENTOWN, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- HNL Lab Medicine is redefining convenience in healthcare with the expansion of its HNL Lab Tests Direct menu, adding dozens of new self-pay tests that empower patients [...]
AdipoPharma Recognized at American Diabetes Association 85th Annual Meeting for PATAS, Its First-in-Class Whole-Body Insulin-Sensitizing Compound
30/06/2025
CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- AdipoPharma , a biotech company headquartered in France with offices in the U.S. and Belgium, was recognized at the American Diabetes Association’s 85 th Annual Meeting this [...]
NADP Reports Dental Benefits Market on Road to Recovery
30/06/2025
Market Continues to Rebound from Pandemic Era DALLAS, June 30, 2025 (GLOBE NEWSWIRE) -- The health of the dental benefits industry showed visible signs of recovery at year-end 2023, following market disruptions [...]
Baylor Genetics’ Chairman and CEO Kengo Takishima Named One of Houston Business Journal’s 2025 Most Admired CEOs
30/06/2025
Award is one of Houston’s most inspiring celebrations of leadership, where CEOs and visionaries are at the helm of the city’s most successful and impactful organizations HOUSTON, June 30, 2025 (GLOBE NEWSWIRE) -- Baylor [...]

Pages